Delivery Order SPE2DB24D2215-SPE2DB25FGSUR

Award Date 4/28/25
Potential Completion Date 4/29/25
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,837.82 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which does not have a set-aside designation, is for the supply of XTAMPZA ER 36 MG CAPSULE 100S, a type of medication. This delivery order contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,706.55 firm fixed-price delivery order is for the supply of XTAMPZA ER 27 MG capsules in 100-count bottles. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award, with ID SPE2DX22D0010|SPE2D825FDF86, was granted by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,711.42 Firm Fixed Price Delivery Order contract is for the provision of XTAMPZA ER CAPS 36MG, a pharmaceutical product. The contract has a period of performance through February 5, 2025 and does not include a set-aside designation, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,587.84 firm-fixed-price delivery order is for the supply of XTAMPZA ER 9 MG CAPSULE 100S, a specialty pharmaceutical product. The contract has an ultimate completion date of October 30, 2024 and was awarded on October 29, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,257.87 firm-fixed-price delivery order is for the supply of XTAMPZA ER 27 MG CAPSULE 100S, a pain medication. The contract has an ultimate completion date of September 26, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
The U.S. government awarded a $2,862.62 firm fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The contract is for the supply of XTAMPZA ER CAPS 36MG, a prescription medication, to the Defense Logistics Agency (DLA) Troop Support Medical. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 held by Amerisourcebergen with the DLA, which serves as the primary vehicle...
This federal contract award with identification number SPE2DX15D3013|SPE2DX24FH2E8 was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, to the prime contractor Amerisourcebergen Drug Corp. The $1,608.74 firm fixed-price delivery order is for the supply of XTAMPZA ER 27 MG CAPSULE 100S, a pharmaceutical product. The contract has a period of performance through February 2, 2024 and does not have a set-aside designation, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $1,384.92 firm fixed price delivery order is for the supply of XTAMPZA ER CAPS 9MG, a specialty pharmaceutical product. The contract has a period of performance through March 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award and has also received an...
This federal contract award, with a ceiling value of $4,028.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XTAMPZA ER 36 MG CAPSULE 100S, a prescription medication. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is May 7, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,379.48, is a Delivery Order awarded under the DLA's Indefinite Delivery Contract (IDC) for providing XTAMPZA ER 9 MG CAPSULE 100S, a specialty pharmaceutical product. Amerisourcebergen holds a $999,999,999 IDC with DLA Troop Support Medical to supply a wide range of...
  • SPE2DB24D2215
    Indefinite Delivery Contract
  • SPE2DB24D2215-SPE2DB25FGSUR
    Delivery Order

This federal contract award, with ID SPE2DB24D2215|SPE2DB25FGSUR, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,808.62 firm fixed-price delivery order is for the supply of 4,568,062,525 units of the prescription medication XTAMPZA ER 27 MG CAPSULE 100S. The contract has an ultimate completion date of April 29, 2025 and does not utilize any set-aside designations, indicating open competition. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle through December 2026, enabling the company to supply a wide range of medical products and supplies to various government agencies, including the Defense Health Agency and U.S. Coast Guard.

Generated 8/3/25, 12:51 AM